Evidence map›Paper›PMID 29944709›Full record

ArticlePloS one2018

Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks.

Veronika I Zarnitsyna, Irina Bulusheva, Andreas Handel, Ira M Longini, M Elizabeth Halloran, Rustom Antia

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Fundamental bound on epidemic overshoot in the SIR model.Journal of the Royal Society, Interface · 2023
    Article
  2. Article
  3. Interplay between cost and effectiveness in influenza vaccine uptake: a vaccination game approach.Proceedings. Mathematical, physical, and engineering sciences · 2019
    Article
  4. A collaborative multiyear, multimodel assessment of seasonal influenza forecasting in the United States.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Veronika I ZarnitsynaDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, 30322, United States of America.ORCID 0000-0003-3096-3695
Irina BulushevaDepartment of Biological and Medical Physics, Moscow Institute of Physics and Technology, Dolgoprudny, 141701, Russia.
Andreas HandelDepartment of Epidemiology and Biostatistics, University of Georgia, Athens, GA, 30602, United States of America.
Ira M LonginiDepartment of Biostatistics, University of Florida, Gainesville, FL, 32611, United States of America.
M Elizabeth HalloranVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, United States of America.
Rustom AntiaDepartment of Biology, Emory University, Atlanta, GA, 30322, United States of America.

Funding

Understanding Transmission with Integrated Genetic and Epidemiologic InferenceU54GM111274 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HALLORAN, M ELIZABETH · 2014 to 2018
$12.5M
Modeling the dynamics and evolution of immune responses to influenza virusesU19AI117891 · NIAID · EMORY UNIVERSITY · PI AHMED, RAFI, ANTIA, RUSTOM NOSHIR · 2015 to 2019
$8.4M
Methods for Evaluating Vaccine EfficacyR37AI032042 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HALLORAN, M ELIZABETH · 2010 to 2019
$5.1M
NIAID NIH HHS R37 AI032042NIAID NIH HHS U19 AI117891NIGMS NIH HHS U54 GM111274
6 · The paper itself

Abstract

For most pathogens, vaccination reduces the spread of the infection and total number of cases; thus, public policy usually advocates maximizing vaccination coverage. We use simple mathematical models to explore how this may be different for pathogens, such as influenza, which exhibit strain variation. Our models predict that the total number of seasonal influenza infections is minimized at an intermediate (rather than maximal) level of vaccination, and, somewhat counter-intuitively, further increasing the level of the vaccination coverage may lead to higher number of influenza infections and be detrimental to the public interest. This arises due to the combined effects of: competition between multiple co-circulating strains; limited breadth of protection afforded by the vaccine; and short-term strain-transcending immunity following natural infection. The study highlights the need for better quantification of the components of vaccine efficacy and longevity of strain-transcending cross-immunity in order to generate nuanced recommendations for influenza vaccine coverage levels.

Indexed as

Disease OutbreaksInfluenza, HumanSeasonsVaccinationHumansInfluenza VaccinesInfluenza Vaccines

Identifiers

PMID29944709
PMCPMC6019388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.